Growth Metrics

Usana Health Sciences (USNA) Amortization of Deferred Charges (2019 - 2021)

Usana Health Sciences has reported Amortization of Deferred Charges over the past 3 years, most recently at $2.2 million for Q4 2021.

  • Quarterly Amortization of Deferred Charges rose 5.51% to $2.2 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $9.1 million through Oct 2021, up 4.78% year-over-year, with the annual reading at $8.8 million for FY2021, 6.03% up from the prior year.
  • Amortization of Deferred Charges was $2.2 million for Q4 2021 at Usana Health Sciences, down from $2.3 million in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $2.3 million in Q1 2021 and troughed at $2.0 million in Q2 2019.
  • The 3-year median for Amortization of Deferred Charges is $2.2 million (2019), against an average of $2.2 million.
  • Year-over-year, Amortization of Deferred Charges grew 11.47% in 2020 and then rose 0.18% in 2021.
  • A 3-year view of Amortization of Deferred Charges shows it stood at $2.2 million in 2019, then decreased by 2.07% to $2.1 million in 2020, then rose by 5.51% to $2.2 million in 2021.
  • Per Business Quant, the three most recent readings for USNA's Amortization of Deferred Charges are $2.2 million (Q4 2021), $2.3 million (Q3 2021), and $2.3 million (Q2 2021).